Search
Home
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Great Place To Work
Analytics
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
Home
Latest
Latest
News
North America
Europe
Asia
Middle East
Global
Fortune 500
Fortune 500
Fortune 500 U.S.
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Finance
Finance
Economy
Banking
Personal Finance
Investing
Real Estate
Energy
Crypto
Tech
Tech
Big Tech
Startups & Venture
AI
Innovation
Cybersecurity
Leadership
Leadership
Future Of Work
Success
C-Suite
Workplace Culture
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Health
Travel & Leisure
Education
Rankings
Rankings
Great Place To Work
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Press Releases
Video
Podcasts
home
home
Merck
Merck
Page 2 of 9
Health
J&J, Merck, Boston Scientific go on $6.4B buying spree
By
Fiona Rutherford
and
Bloomberg
January 8, 2024
Leadership
Former Merck CEO Ken Frazier on the responsibility of CEOs to uphold principles despite politics
By
Fortune Editors
November 9, 2023
Health
U.S. cancer patients face nationwide shortages of life-saving chemo drugs as ‘race to the bottom’ makes their production unprofitable
By
Christiaan Hetzner
October 28, 2023
Leadership
Ken Frazier, long one of the few Black Fortune 500 CEOs, is fighting against ‘the vestiges of the way this country was run for 400 years’
By
Trey Williams
October 3, 2023
Newsletters
Hiring managers say they support dropping college degree requirements, but few actually do so. The reasons why might surprise you
By
Ruth Umoh
September 13, 2023
Health
Overwhelmed by a massive outbreak, China authorizes emergency use of Merck COVID pill Lagevrio
By
Bloomberg
December 30, 2022
Finance
The world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By
Paige McGlauflin
August 15, 2022
Commentary
It’s time for companies to do less
By
Daryl Brewster
May 5, 2022
Health
The most innovative and inventive drug companies of 2022 set the foundation for success before the pandemic
By
Sy Mukherjee
and
IDEA Pharma
April 20, 2022
Health
A new batch of COVID pills are in focus as daily life reopens. Here’s how the treatments work—and how well
By
Jason Gale
,
John Lauerman
and
Bloomberg
February 15, 2022
Health
New York City will home-deliver free antiviral pills to COVID-19 patients
By
Ian Fisher
and
Bloomberg
January 31, 2022
Health
FDA authorizes Merck COVID pill a day after approving Pfizer’s
By
Matthew Perrone
and
The Associated Press
December 23, 2021
Health
FDA set to authorize Pfizer and Merck COVID pills this week
By
Josh Wingrove
,
Jennifer Jacobs
,
Robert Langreth
and
Bloomberg
December 21, 2021
Health
GSK says its COVID antibody therapy works against Omicron. Here’s what other drugmakers say about their treatments
By
Sophie Mellor
December 7, 2021
Health
Germany will make COVID vaccinations mandatory if Angela Merkel gets her way
By
Christiaan Hetzner
December 2, 2021
Most Popular
Economy
America's $38 trillion national debt 'exacerbates generational imbalances' with Gen Z and millennials paying the price,...
By
Eleanor Pringle
Innovation
An MIT roboticist who cofounded bankrupt Roomba maker iRobot says Elon Musk's vision of humanoid robot assistants is...
By
Marco Quiroz-Gutierrez
Success
As millions of Gen Zers face unemployment, McDonald's CEO dishes out some tough love career...
By
Preston Fore